Articles with public access mandates - Angela ChouLearn more
Not available anywhere: 2
Genomic analyses identify molecular subtypes of pancreatic cancer
P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ...
Nature 531 (7592), 47-52, 2016
Mandates: US National Institutes of Health, National Health and Medical Research …
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater
DK Chang, NB Jamieson, AL Johns, CJ Scarlett, M Pajic, A Chou, ...
Journal of clinical oncology 31 (10), 1348-1356, 2013
Mandates: National Health and Medical Research Council, Australia
Available somewhere: 41
Whole genomes redefine the mutational landscape of pancreatic cancer
N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ...
Nature 518 (7540), 495-501, 2015
Mandates: US National Institutes of Health, National Health and Medical Research …
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ...
Nature 491 (7424), 399-405, 2012
Mandates: US National Institutes of Health, National Health and Medical Research …
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
Mandates: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Whole-genome landscape of pancreatic neuroendocrine tumours
A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ...
Nature 543 (7643), 65-71, 2017
Mandates: US National Institutes of Health, National Health and Medical Research …
The prognostic and predictive value of serum CA19. 9 in pancreatic cancer
JL Humphris, DK Chang, AL Johns, CJ Scarlett, M Pajic, MD Jones, ...
Annals of oncology 23 (7), 1713-1722, 2012
Mandates: National Health and Medical Research Council, Australia
The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma
PA Pérez-Mancera, AG Rust, L Van Der Weyden, G Kristiansen, A Li, ...
Nature 486 (7402), 266-270, 2012
Mandates: US National Institutes of Health, German Research Foundation, Cancer Research UK
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients
AJ Gill, O Hes, T Papathomas, M Šedivcová, PH Tan, A Agaimy, ...
The American journal of surgical pathology 38 (12), 1588-1602, 2014
Mandates: US National Institutes of Health
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
C Vennin, VT Chin, SC Warren, MC Lucas, D Herrmann, A Magenau, ...
Science translational medicine 9 (384), eaai8504, 2017
Mandates: US National Institutes of Health, American Heart Association, Australian …
Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial
LA Chantrill, AM Nagrial, C Watson, AL Johns, M Martyn-Smith, ...
Clinical cancer research 21 (9), 2029-2037, 2015
Mandates: National Health and Medical Research Council, Australia, Cancer Research UK …
Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
KM Mann, JM Ward, CCK Yew, A Kovochich, DW Dawson, MA Black, ...
Proceedings of the National Academy of Sciences 109 (16), 5934-5941, 2012
Mandates: US National Institutes of Health, Cancer Research UK
Hypermutation in pancreatic cancer
JL Humphris, AM Patch, K Nones, PJ Bailey, AL Johns, S McKay, ...
Gastroenterology 152 (1), 68-74. e2, 2017
Mandates: US National Institutes of Health, National Health and Medical Research …
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome
CW Toon, MD Walsh, A Chou, D Capper, A Clarkson, L Sioson, S Clarke, ...
The American journal of surgical pathology 37 (10), 1592-1602, 2013
Mandates: US National Institutes of Health
Clinical and molecular characterization of HER2amplified-pancreatic cancer
A Chou, N Waddell, MJ Cowley, AJ Gill, DK Chang, AM Patch, K Nones, ...
Genome medicine 5, 1-11, 2013
Mandates: National Health and Medical Research Council, Australia
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
A Chou, D Froio, AM Nagrial, A Parkin, KJ Murphy, VT Chin, D Wohl, ...
Gut 67 (12), 2142-2155, 2018
Mandates: Australian Research Council, National Health and Medical Research Council …
A single-cell tumor immune atlas for precision oncology
P Nieto, M Elosua-Bayes, JL Trincado, D Marchese, R Massoni-Badosa, ...
Genome research 31 (10), 1913-1926, 2021
Mandates: National Health and Medical Research Council, Australia, European Commission …
Targeting DNA damage response and replication stress in pancreatic cancer
SB Dreyer, R Upstill-Goddard, V Paulus-Hock, C Paris, EM Lampraki, ...
Gastroenterology 160 (1), 362-377. e13, 2021
Mandates: US National Institutes of Health, National Health and Medical Research …
HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer
H Brunton, G Caligiuri, R Cunningham, R Upstill-Goddard, UM Bailey, ...
Cell reports 31 (6), 2020
Mandates: US National Institutes of Health, National Health and Medical Research …
International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma
B Xu, TL Fuchs, S Ahmadi, M Alghamdi, B Alzumaili, MA Bani, E Baudin, ...
Journal of Clinical Oncology 40 (1), 96-104, 2022
Mandates: US National Institutes of Health, Government of Italy
Publication and funding information is determined automatically by a computer program